OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
May 15, 2022
The need for sustainability and early considerations of a lyophilization strategy grow more pertinent on the back of growing biologics volume.
CGTs offer hope for the future of treatments, but the costly manufacturing, slow turnaround time, and need for supplies hinder progress.
The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.
Several steps need be taken to achieve lights-out, fully automated operations.
May 13, 2022
Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.
May 12, 2022
PCI Pharma Services is investing $100 million in manufacturing capabilities and capacity expansion to its Bedford, NH facility.
May 10, 2022
908 Devices and CPI have formed a collaboration to optimize cell culture media to allow for improved process control.
Societal CDMO has signed a three-year manufacturing and supply agreement with InfectoPharm for Ritalin LA in Europe.
May 09, 2022
MilliporeSigma’s ZooMAb antibodies have been recognized for their low environmental impact by My Green Lab.
May 06, 2022
Schott has announced the inauguration of its new high-end polymer prefillable syringe manufacturing facility in Mülheim, Germany.